Japan

R&D

How Japan is pioneering the future of oncology clinical tria...

Discover how Japan is leading the way in oncology clinical trials through the implementation of decentralised clinical trials

News

Shionogi gets approval in Japan for ADHD digital therapeutic

Shionogi will market the EndeavorRide app, originally licensed from Akili, in Japan following its approval by the MHLW regulator.

News

First global approval for Daiichi Sankyo's Dato-DXd

Daiichi Sankyo has claimed its first approval, in Japan, for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan.

News

Eisai debuts biliary tract cancer drug in Japan

Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the FGFR-targeting drug

News

traditional red and black painted bamboo walkway in Japan

Lilly gets second approval, in Japan, for Alzheimer's drug

Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug.

News

Investors take issue with Taisho Pharma’s buyout price

Two investment funds have decided to contest Taisho Pharma’s recently announced management buyout plan in court, after failing to reach an agreement on the price.

How Japan is pioneering the future of oncology clinical tria...

Shionogi gets approval in Japan for ADHD digital therapeutic

First global approval for Daiichi Sankyo's Dato-DXd

Eisai debuts biliary tract cancer drug in Japan

Lilly gets second approval, in Japan, for Alzheimer's drug

Investors take issue with Taisho Pharma’s buyout price

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Japan

Editor's Picks